It should go without saying how precision medicine is paramount for XXY’s especially given we are genotypical females and how standard pharmacology designed for males does not always adhere to the type of expected outcomes and in some instances not at all. An additional difficulty is how Testosterone is viewed as the standard treatment of care resulting in some level of virilisation and with it a high rate of difficulty for doctors to see us as anything other than male.
The new frontier of medicine is precision. The safety and efficacy of a medical treatments change a lot according to the patient’s specific characteristics ranging from sex and gender to proteomics, genomics, socioeconomic status, race, ethnicity and beyond . Antonella Santuccione Chadha, a medical doctor and a researcher with great experience in the field of mental and neurological disorders, is keenly interested in removing bias when developing solutions for mental and neurological diseases to achieve precision medicines. Its mission is the development of targeted treatments, with the help of artificial intelligence because “the average patient does not exist in reality” Antonella Santuccione Chadha is one of the co-founders and the CEO of the Women’s Brain Project.